Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-01

Clinical Trial Update: Prophylaxis of Neuropathic Pain by mémantine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing memantine for prophylaxis of neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Neuropathic Pain | Phase 3 | Status: COMPLETED